Effectiveness and safety of iguratimod treatment in patients with active rheumatoid arthritis in Chinese: A nationwide, prospective real-world study

• Main Authors: Rong Mu (Author), Chun Li (Author), Xiaomei Li (Author), Yao Ke (Author), Ling Zhao (Author), Lin Chen (Author), Rui Wu (Author), Zhenbiao Wu (Author), Xiaoxia Zuo (Author), Yanli Xie (Author), Jinwei Chen (Author), Wei Wei (Author), Yi Liu (Author), Zhijun Li (Author), Lie Dai (Author), Lingyun Sun (Author), Xiangyuan Liu (Author), Zhanguo Li (Author)
• Format: Book
• Published: Elsevier, 2021-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: There is heterogeneity in the clinical manifestations and responses to drugs in RA patients due to variety of factors such as genes and environment. Despite advances in the treatment of rheumatoid arthritis (RA), approximately 40% of RA patients still do not achieve primary clinical outc...